American Association for the Advancement of Science, Science Translational Medicine, 450(10), 2018
DOI: 10.1126/scitranslmed.aar3342
Full text: Unavailable
Loss of membrane MHC class I protein expression in most of tumor cells in advanced melanomas predicts primary resistance to anti–CTLA-4, but not anti-PD1, treatment.